NEW YORK, May 1 (GenomeWeb News) - Danish drug developer Santaris Pharma said today that it has created a MicroRNA Research Consortium in partnership with the Department for Medical Biochemistry and Genetics at the University of Copenhagen.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.